CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemothe ...
Phase 2
Kansas City, Kansas, United States and 8 other locations
Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNB ...
Phase 1, Phase 2
Kansas City, Kansas, United States and 6 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
Kansas City, Missouri, United States and 210 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Kansas City, Kansas, United States and 516 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Kansas City, Kansas, United States and 505 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Westwood, Kansas, United States and 275 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Westwood, Kansas, United States and 257 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...
Phase 1, Phase 2
Westwood, Kansas, United States and 39 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), end...
Phase 1, Phase 2
Kansas City, Missouri, United States and 123 other locations
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs ...
Phase 2
Kansas City, Missouri, United States and 121 other locations
Clinical trials
Research sites
Resources
Legal